Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
---|
Total Revenue
|
5,356,000
|
5,923,000
|
5,423,000
|
5,541,000
| Cost of Revenue | 3,749,000 | 4,056,000 | 3,743,000 | 3,768,000 | |
Gross Profit
|
1,607,000
|
1,867,000
|
1,680,000
|
1,773,000
| |
|
Operating Expenses |
|
Research Development | 154,000 | 160,000 | 161,000 | 161,000 |
|
Selling General and Administrative | 1,072,000 | 1,165,000 | 1,106,000 | 1,150,000 |
|
Non Recurring | (7,000) | 93,000 | 14,000 | 29,000 |
|
Others | 83,000 | 82,000 | 82,000 | 82,000 |
|
|
|
Total Operating Expenses | 1,302,000 | 1,500,000 | 1,363,000 | 1,422,000 | | |
Operating Income or Loss
|
305,000
|
367,000
|
317,000
|
351,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 305,000 | 367,000 | 317,000 | 351,000 |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | 305,000 | 367,000 | 317,000 | 351,000 |
|
Income Tax Expense | 52,000 | 71,000 | 63,000 | 66,000 |
|
Minority Interest | (4,000) | (8,000) | (6,000) | (7,000) |
|
|
|
Net Income From Continuing Ops | 296,000 | 335,000 | 282,000 | 309,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
296,000
|
335,000
|
282,000
|
309,000
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
296,000
|
335,000
|
282,000
|
309,000
|
|